|
|
Volumn 288, Issue 5474, 2000, Pages 2171-2173
|
|
Something to be done: Treating HIV/AIDS
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIRETROVIRUS AGENT;
FLUCONAZOLE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
DEVELOPED COUNTRY;
DEVELOPING COUNTRY;
DRUG COST;
DRUG INDUSTRY;
HEALTH CARE DELIVERY;
HEALTH ECONOMICS;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INFECTION CONTROL;
MORBIDITY;
MORTALITY;
OPPORTUNISTIC INFECTION;
PRIORITY JOURNAL;
REVIEW;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
ANTI-HIV AGENTS;
DELIVERY OF HEALTH CARE;
DEVELOPING COUNTRIES;
DRUG COSTS;
DRUG INDUSTRY;
DRUG UTILIZATION;
FINANCIAL SUPPORT;
HEALTH POLICY;
HIV INFECTIONS;
HUMANS;
INTERNATIONAL COOPERATION;
UNITED STATES;
WORLD HEALTH;
HUMAN IMMUNODEFICIENCY VIRUS;
|
|
EID: 0034705552
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.288.5474.2171 Document Type: Review |
|
Times cited : (13)
|
|
References (0)
|
